Our findings are supported by a previous study demonstrating that AGOM treatment decreased the release of cytokines (TNF-α, IL-6 and IL-1β) and restored BDNF levels and the activity of the antioxidant enzymes CAT and GPx in the brain in an HFD-induced anxiety-like behavior model [23]. This evidence concerns the gene IL1B and Anxiety.